Preferential binding of unusually long peptides to MHC class I and its influence on the selection of target peptides for T cell recognition

Molecular Immunology

Volumn 45, Issue 6, 2008, Pages 1818-1824

  Burrows, Jacqueline M ^a   Bell, Melissa J ^a   Brennan, Rebekah ^a   Miles, John J ^a,b   Khanna, Rajiv ^a   Burrows, Scott R ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Antigen presentation processing; CTL; Human; MHC class I; Viral

Indexed keywords

HLA ANTIGEN CLASS 1; HLA B35 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS PROTEIN;

ALLELE; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; T LYMPHOCYTE;

ANTIGEN PRESENTATION; CELL LINE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-B35 ANTIGEN; HUMANS; PEPTIDES; PROTEIN BINDING; T-LYMPHOCYTES, CYTOTOXIC;

EID: 38949169871     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.09.026     Document Type: Article

References (29)

1. + T cell response: lessons from the EBV nuclear antigen EBNA1. J. Immunol. 165 (2000) 7078-7087
2. Blake N., Lee S., Redchenko I., Thomas W., Steven N., Leese A., Steigerwald-Mullen P., Kurilla M.G., Frappier L., and Rickinson A. Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity 7 (1997) 791-802
3. Bouvier M., and Wiley D.C. Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science 265 (1994) 398-402
4. Burrows S.R., Rossjohn J., and McCluskey J. Have we cut ourselves too short in mapping CTL epitopes?. Trends Immunol. 27 (2006) 11-16
5. Burrows J.M., Wynn K.K., Tynan F.E., Archbold J., Miles J.J., Bell M.J., Brennan R.M., Walker S., McCluskey J., Rossjohn J., Khanna R., and Burrows S.R. The impact of HLA-B micropolymorphism outside primary peptide anchor pockets on the CTL response to CMV. Eur. J. Immunol. 37 (2007) 946-953
6. Crough T., Burrows J.M., Fazou C., Walker S., Davenport M.P., and Khanna R. Contemporaneous fluctuations in T cell responses to persistent herpes virus infections. Eur. J. Immunol. 35 (2005) 139-149
7. Falk K., Rotzschke O., Grahovac B., Schendel D., Stevanovic S., Jung G., and Rammensee H.G. Peptide motifs of HLA-B35 and -B37 molecules. Immunogenetics 38 (1993) 161-162
8. Green K.J., Miles J.J., Tellam J., van Zuylen W.J., Connolly G., and Burrows S.R. Potent T cell response to a class I-binding 13-mer viral epitope and the influence of HLA micropolymorphism in controlling epitope length. Eur. J. Immunol. 34 (2004) 2510-2519
9. Guo H.C., Jardetzky T.S., Garrett T.P., Lane W.S., Strominger J.L., and Wiley D.C. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 360 (1992) 364-366
10. Hickman H.D., Luis A.D., Buchli R., Few S.R., Sathiamurthy M., VanGundy R.S., Giberson C.F., and Hildebrand W.H. Toward a definition of self: proteomic evaluation of the class I peptide repertoire. J. Immunol. 172 (2004) 2944-2952
11. Hill A.V., Elvin J., Willis A.C., Aidoo M., Allsopp C.E., Gotch F.M., Gao X.M., Takiguchi M., Greenwood B.M., Townsend A.R., McMichael A.J., and Whittle H.C. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360 (1992) 434-439
12. Khanna R., Silins S.L., Weng Z., Gatchell D., Burrows S.R., and Cooper L. Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction. Eur. J. Immunol. 29 (1999) 1587-1597
13. Miles J.J., Borg N.A., Brennan R.M., Tynan F.E., Kjer-Nielsen L., Silins S.L., Bell M.J., Burrows J.M., McCluskey J., Rossjohn J., and Burrows S.R. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope. J. Immunol. 177 (2006) 6804-6814
14. Miles J.J., Elhassen D., Borg N.A., Silins S.L., Tynan F.E., Burrows J.M., Purcell A.W., Kjer-Nielsen L., Rossjohn J., Burrows S.R., and McCluskey J. CTL recognition of a bulged viral peptide involves biased TCR selection. J. Immunol. 175 (2005) 3826-3834
15. Parker K.C., Bednarek M.A., and Coligan J.E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152 (1994) 163-175
16. Prilliman K.R., Lindsey M., Jackson K.W., Cole J., Bonner R., and Hildebrand W.H. Complexity among constituents of the HLA-B*1501 peptide motif. Immunogenetics 48 (1998) 89-97
17. Probst-Kepper M., Hecht H.J., Herrmann H., Janke V., Ocklenburg F., Klempnauer J., van den Eynde B.J., and Weiss S. Conformational restraints and flexibility of 14-meric peptides in complex with HLA-B*3501. J. Immunol. 173 (2004) 5610-5616
18. Rammensee H.G., Falk K., and Rotzschke O. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11 (1993) 213-244
19. Salter R.D., and Cresswell P. Impaired assembly and transport of HLA-A and -B antigens in a mutant T × B cell hybrid. EMBO. J. 5 (1986) 943-949
20. Serwold T., Gaw S., and Shastri N. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules. Nat. Immunol. 2 (2001) 644-651
21. Smith K.J., Reid S.W., Harlos K., McMichael A.J., Stuart D.I., Bell J.I., and Jones E.Y. Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity 4 (1996) 215-228
22. Speir J.A., Stevens J., Joly E., Butcher G.W., and Wilson I.A. Two different, highly exposed, bulged structures for an unusually long peptide bound to rat MHC class I RT1-Aa. Immunity 14 (2001) 81-92
23. Steinle A., Falk K., Rotzschke O., Gnau V., Stevanovic S., Jung G., Schendel D.J., and Rammensee H.G. Motif of HLA-B*3503 peptide ligands. Immunogenetics 43 (1996) 105-107
24. Stewart-Jones G.B., Gillespie G., Overton I.M., Kaul R., Roche P., McMichael A.J., Rowland-Jones S., and Jones E.Y. Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression. J. Immunol. 175 (2005) 2459-2468
25. Stuber G., Leder G.H., Storkus W.T., Lotze M.T., Modrow S., Szekely L., Wolf H., Klein E., Karre K., and Klein G. Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay. Eur. J. Immunol. 24 (1994) 765-768
26. Tynan F.E., Borg N.A., Miles J.J., Beddoe T., El-Hassen D., Silins S.L., van Zuylen W.J., Purcell A.W., Kjer-Nielsen L., McCluskey J., Burrows S.R., and Rossjohn J. High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I Implications for T-cell receptor engagement and T-cell immunodominance. J. Biol. Chem. 280 (2005) 23900-23909
27. Tynan F.E., Burrows S.R., Buckle A.M., Clements C.S., Borg N.A., Miles J.J., Beddoe T., Whisstock J.C., Wilce M.C., Silins S.L., Burrows J.M., Kjer-Nielsen L., Kostenko L., Purcell A.W., McCluskey J., and Rossjohn J. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Nat. Immunol. 6 (2005) 1114-1122
28. Tynan F.E., Elhassen D., Purcell A.W., Burrows J.M., Borg N.A., Miles J.J., Williamson N.A., Green K.J., Tellam J., Kjer-Nielsen L., McCluskey J., Rossjohn J., and Burrows S.R. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation. J. Exp. Med. 202 (2005) 1249-1260
29. Tynan F.E., Reid H.H., Kjer-Nielsen L., Miles J.J., Wilce M.C., Kostenko L., Borg N.A., Williamson N.A., Beddoe T., Purcell A.W., Burrows S.R., McCluskey J., and Rossjohn J. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat. Immunol. 8 (2007) 268-276